Novartis

They assured that they will work towards developing innovations to fight the COVID-19 pandemic, ensuring their timely availability…

The financial details of the transaction have not been revealed but the facility in Germany’s Marburg will be converted to be…

Johnson & Johnson maintained its top position with MCap growth of 7.2 per cent on a QoQ basis

The analysis evaluated the efficacy and tolerability of inclisiran on top of a maximally tolerated dose of statins, in two studies…

Ofatumumab was first approved by the FDA in 2009 for the treatment of chronic lymphocytic leukaemia (CLL)

The one-a-day oral drug is viewed as a potential a rival to Spinraza, which is administered every four months via spinal infusion

In recent years, Cipla also had agreements with Roche India, Mannkind USA, Stempeutics Research, Novartis and Luye Pharma to…

The move comes in the wake of US FDA’s decision to EUA for hydroxychloroquine and chloroquine against COVID-19

Fingolimod is a generic version of Novartis Pharmaceuticals' Gilenya Capsules, 0.5 mg

Among the positive performances were Takeda Pharmaceutical and Daiichi Sankyo, which reported more than 100 per cent YoY growth in…